<--- Back to Details
First PageDocument Content
Pharmaceutical sciences / Business / Biotechnology / Celgene / Summit /  New Jersey / Bayer / Aflibercept / Versant / Pharmaceutical industry in China / Regeneron / Pharmaceutical industry
Date: 2014-01-21 19:48:19
Pharmaceutical sciences
Business
Biotechnology
Celgene
Summit
New Jersey
Bayer
Aflibercept
Versant
Pharmaceutical industry in China
Regeneron
Pharmaceutical industry

Dow Jones VentureWire Versant-Backed Inception Sciences Creates Eye-Drug Startup With Bayer Healthcare th November

Add to Reading List

Source URL: www.versantventures.com

Download Document from Source Website

File Size: 33,60 KB

Share Document on Facebook

Similar Documents

Celgene Blue-EPS- NEW.eps

Celgene Blue-EPS- NEW.eps

DocID: 1tXF2 - View Document

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use REVLIMID® safely and effectively. See full prescribing information for REVLIMID. REVLIMID [lenalidomide] capsules,

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use REVLIMID® safely and effectively. See full prescribing information for REVLIMID. REVLIMID [lenalidomide] capsules,

DocID: 1tonS - View Document

Celgene IncMississauga Road Suite 600 Mississauga, ON L5N 7Y2 Tel: Toll-free:

Celgene IncMississauga Road Suite 600 Mississauga, ON L5N 7Y2 Tel: Toll-free:

DocID: 1thuA - View Document

Celgene IncMississauga Road Suite 600 Mississauga, ON L5N 7Y2 Tel: Toll-free:

Celgene IncMississauga Road Suite 600 Mississauga, ON L5N 7Y2 Tel: Toll-free:

DocID: 1tgVI - View Document

Celgene IncMississauga Road Suite 600 Mississauga, ON L5N 7Y2 Tél. : Sans frais :

Celgene IncMississauga Road Suite 600 Mississauga, ON L5N 7Y2 Tél. : Sans frais :

DocID: 1t2Vj - View Document